BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1835136)

  • 21. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201.
    Sinusas AJ; Watson DD; Cannon JM; Beller GA
    J Am Coll Cardiol; 1989 Dec; 14(7):1785-93. PubMed ID: 2584570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New agents labelled with technetium 99m for myocardial perfusion imaging.
    Taillefer R
    Can Assoc Radiol J; 1992 Aug; 43(4):258-66. PubMed ID: 1386280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial extraction of teboroxime: effects of teboroxime interaction with blood.
    Rumsey WL; Rosenspire KC; Nunn AD
    J Nucl Med; 1992 Jan; 33(1):94-101. PubMed ID: 1530970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between regional myocardial blood flow and the distribution of 99mTc-sestamibi in the presence of total coronary artery occlusion.
    Mousa SA; Cooney JM; Williams SJ
    Am Heart J; 1990 Apr; 119(4):842-7. PubMed ID: 2138845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial extraction of technetium-99m-[2-(1-methoxybutyl) isonitrile] in the isolated rabbit heart: a myocardial perfusion agent with high extraction and stable retention.
    Dahlberg ST; Meerdink DJ; Gilmore MP; Leppo JA
    J Nucl Med; 1993 Jun; 34(6):927-31. PubMed ID: 8509860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Technetium-99m-labeled myocardial perfusion agents: Are they better than thallium-201?
    Kailasnath P; Sinusas AJ
    Cardiol Rev; 2001; 9(3):160-72. PubMed ID: 11304401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of neutral and cationic myocardial perfusion agents: characteristics of accumulation in cultured cells.
    Kronauge JF; Chiu ML; Cone JS; Davison A; Holman BL; Jones AG; Piwnica-Worms D
    Int J Rad Appl Instrum B; 1992 Feb; 19(2):141-8. PubMed ID: 1601667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial uptake of 99mTc-tetrofosmin, sestamibi, and 201Tl in a model of acute coronary reperfusion.
    Takahashi N; Reinhardt CP; Marcel R; Leppo JA
    Circulation; 1996 Nov; 94(10):2605-13. PubMed ID: 8921807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
    Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
    J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction.
    Kauffman GJ; Boyne TS; Watson DD; Smith WH; Beller GA
    J Am Coll Cardiol; 1996 Jun; 27(7):1592-7. PubMed ID: 8636541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experience with technetium-99m teboroxime, a neutral, lipophilic myocardial perfusion imaging agent.
    Johnson LL; Seldin DW
    Am J Cardiol; 1990 Oct; 66(13):63E-67E. PubMed ID: 2220625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of myocardial viability: Tl-201 versus sestamibi versus teboroxime compared with FDG uptake.
    Kiser JW; Drane WE; Mastin ST; Nicole MW
    Clin Nucl Med; 1998 Jul; 23(7):432-6. PubMed ID: 9676947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201.
    Maublant JC; Zhang Z; Rapp M; Ollier M; Michelot J; Veyre A
    J Nucl Med; 1993 Nov; 34(11):1949-52. PubMed ID: 8229240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Technetium-99m hexakis 2-methoxy-2-isobutyl isonitrile and thallium-201 extraction, washout, and retention at varying coronary flow rates in rabbit heart.
    Marshall RC; Leidholdt EM; Zhang DY; Barnett CA
    Circulation; 1990 Sep; 82(3):998-1007. PubMed ID: 2394016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow.
    Beanlands R; Muzik O; Nguyen N; Petry N; Schwaiger M
    J Am Coll Cardiol; 1992 Sep; 20(3):712-9. PubMed ID: 1512353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial uptake of thallium 201 and technetium 99m-labeled sestamibi after ischemia and reperfusion: comparison by quantitative dual-tracer autoradiography in rabbits.
    Weinstein H; Reinhardt CP; Wironen JF; Leppo JA
    J Nucl Cardiol; 1994; 1(4):351-64. PubMed ID: 9420718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial uptake of (99m)Tc-N-NOET and (201)Tl during dobutamine infusion. Comparison with adenosine stress.
    Calnon DA; Ruiz M; Vanzetto G; Watson DD; Beller GA; Glover DK
    Circulation; 1999 Oct; 100(15):1653-9. PubMed ID: 10517738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile.
    Cuocolo A; Pace L; Ricciardelli B; Chiariello M; Trimarco B; Salvatore M
    J Nucl Med; 1992 Apr; 33(4):505-11. PubMed ID: 1552332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative analysis of planar technetium-99m-sestamibi myocardial perfusion images using modified background subtraction.
    Koster K; Wackers FJ; Mattera JA; Fetterman RC
    J Nucl Med; 1990 Aug; 31(8):1400-8. PubMed ID: 2143529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of myocardial blood flow using a co-injection technique for technetium-99m-teboroxime, technetium-96-sestamibi and thallium-201.
    Di Rocco RJ; Rumsey WL; Kuczynski BL; Linder KE; Pirro JP; Narra RK; Nunn AD
    J Nucl Med; 1992 Jun; 33(6):1152-9. PubMed ID: 1534576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.